发明名称 PYRIMIDONE COMPOUNDS
摘要 A pyrimidone derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof: wherein X represents hydrogen atom and Y represents hydroxyl group, or X represents fluorine atom and Y represents hydrogen atom; R1 represents a C1-6 alkyl group; R2 represents a morpholin-4-yl group which may be substituted, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).
申请公布号 US2012220591(A1) 申请公布日期 2012.08.30
申请号 US201013389504 申请日期 2010.08.11
申请人 SAKAI DAIKI;NAKAYAMA KAZUKI;WATANABE KAZUTOSHI;SANOFI;MITSUBISHI TANABE PHARMA CORPORATION 发明人 SAKAI DAIKI;NAKAYAMA KAZUKI;WATANABE KAZUTOSHI
分类号 A61K31/5377;A61P3/04;A61P3/10;A61P9/10;A61P25/00;A61P25/02;A61P25/16;A61P25/18;A61P25/28;A61P27/02;A61P27/06;A61P33/06;A61P35/00;A61P35/02;C07D413/14 主分类号 A61K31/5377
代理机构 代理人
主权项
地址